Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the
gastrointestinal tract. It is well established that the gut microbiome has a profound impact on …

The plasticity of the gut microbiota (GM) creates an opportunity to reshape the biological
output of gut microbes by manipulating external factors. It is well known that edible fungal …

Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders that fall into
two main categories: Crohn's disease (CD) and ulcerative colitis (UC). The gastrointestinal …

Dysbiosis of human gut microbiota has been reported in association with ulcerative colitis
(UC) in both children and adults using either 16S rRNA gene or shotgun sequencing data …

Background Numerous studies have examined the gut microbial ecology of patients with
Crohn's disease (CD) and ulcerative colitis, but inflammatory bowel disease–associated …

The etiopathogenesis of Inflammatory bowel disease (IBD) is a result of a complex
interaction between host immune response, the gut microbiome and environmental factors …

Background Previous randomized controlled trials (RCTs) suggested that gut microbiota-
based therapies may be effective in treating autoimmune diseases, but a systematic …

Background Inflammatory bowel disease (IBD) is a chronic relapsing-remitting disease. An
adverse immune reaction toward the intestinal microbiota is involved in the pathophysiology …

Background Emerging evidence suggests that gut microbiota plays a predominant role in
Crohn's disease (CD). However, the microbiome alterations in the early stage of CD patients …

Simple Summary Besides the already known factors that increase the risk of breast cancer,
like hormonal treatment, heredity, and obesity, growing evidence exists that intestinal …